EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma
Qi-Wen Fan(City College of San Francisco), William A. Weiss(City College of San Francisco), Michael Weller(University Hospital of Zurich), Natalia Jura(QB3), Petra Zipper(German Cancer Research Center), Robyn A. Wong(City of Hope), Kevan M. Shokat(Howard Hughes Medical Institute), W. Clay Gustafson(Revolution Medicines (United States)), Elizabeth Charron(University of California, San Francisco), Justin Chen(Stanford University), Jasmine Lau(UCSF Helen Diller Family Comprehensive Cancer Center), Guido Reifenberger(Düsseldorf University Hospital), Christine Cheng(University of California, San Francisco), Christiane B. Knobbe‐Thomsen(German Cancer Research Center)
Cited by 264
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k